|Awarded On||August 16, 2023|
|Title||Expansion of HPV Vaccination Among Survivors of Childhood Cancer|
|Award Mechanism||Primary Prevention of Cancer|
|Institution/Organization||The University of Texas Health Science Center at San Antonio|
|Principal Investigator/Program Director||Allison Grimes|
*Pending contract negotiation
Human papillomavirus (HPV) is known to cause most cervical, anal, and oropharyngeal cancers, and a large proportion of vaginal, vulvar, and penile malignancies. Every year nearly 39,000 new cases of HPV-related cancers are diagnosed in the United States alone. This incidence persists nearly a decade following the launch of the HPV vaccine in 2006, and in fact is rising with continued poor HPV vaccine uptake. In 2016, only 43% of females and 32% of males completed the 3-dose series and rates in Texas are even lower where HPV-related malignancies are highest among the state's predominately Hispanic population. Thus, HPV vaccine initiatives targeting in Texas are critical, beginning with ...